Renal MAG3/DTPA & Captopril
- A renal scan is a movie, not a snapshot: you inject a tracer and watch the kidneys grab it, filter it, and pee it out over time.
- MAG3 is secreted by the tubules and DTPA is filtered by the glomerulus — two different tracers that answer slightly different questions about kidney function and drainage.
- The big two clinical questions are "Is this kidney obstructed?" (diuretic/Lasix study) and "Is a narrow renal artery causing the high blood pressure?" (captopril study).
- For obstruction, you give furosemide and watch whether the tracer washes out; a slow, stubborn washout means the plumbing is actually blocked, not just baggy.
- For the captopril study, an ACE inhibitor unmasks renovascular hypertension by making the affected kidney's curve get worse after the drug.
Most imaging hands you a frozen instant: here is the kidney, here is the stone, the end. A renal scan is different. It's a time-lapse of your kidneys doing their actual job — sipping a tracer out of the blood, concentrating it, and flushing it down the ureters — captured as a curve that rises and then falls. Once you realize you're watching a process, the whole study suddenly makes sense.
Two tracers, two jobs
Both tracers are technetium-99m tagged molecules, but they get handled by the kidney in different ways, and that difference is the whole point.
| Tracer | How the kidney handles it | Best for |
|---|---|---|
| MAG3 (mercaptoacetyltriglycine) | Actively secreted by the renal tubules; high extraction even when function is poor | The workhorse — obstruction, function, transplants, sick kidneys |
| DTPA (diethylenetriaminepentaacetic acid) | Purely filtered by the glomerulus | Estimating glomerular filtration; needs reasonably good function to look good |
Think of the kidney as a nightclub. DTPA only gets in through the front door (glomerular filtration), so if the bouncer is slow — bad kidney function — the images look thin and noisy. MAG3 has a VIP back entrance too (tubular secretion), so it gets pulled into the kidney efficiently even when function is mediocre. That's why MAG3 is the everyday favorite, especially for poorly functioning or transplant kidneys.
When function is borderline or you're imaging a transplant, reach for MAG3. Its tubular secretion gives you crisp images even when a filtration-only tracer like DTPA would look washed out and useless.
The renogram curve
The output is a renogram — a graph of tracer counts in each kidney over time, drawn as two curves you compare side by side. A normal curve does three things: shoots up as blood delivers tracer, peaks as the kidney concentrates it, then slopes back down as the tracer drains away into the bladder.
So you read it in three acts: perfusion (does blood reach the kidney?), function (does it take up and concentrate the tracer?), and drainage (does it let go?). Each kidney gets its own curve, and the asymmetry between them is where the story usually lives.
Question 1: Is it actually obstructed? (the diuretic / Lasix study)
Here's the trap. A dilated, floppy collecting system holds a lot of urine, so tracer pools in it and the curve climbs and just... sits there. That looks alarming, but a baggy, non-obstructed system is like a wide lazy river — slow-moving but not blocked. A truly obstructed system is a kinked garden hose: water genuinely can't get past.
To tell them apart, you give furosemide (Lasix) and crank up urine flow. Now you watch what happens:
- No obstruction: the flood of urine flushes the pooled tracer out and the curve drops nicely.
- Obstruction: even with the diuretic flogging the kidney, the tracer won't budge — the curve stays flat or keeps rising.
The standard summary number is the washout half-time (T½): how long it takes for half the tracer to clear after the diuretic. A prompt washout argues against obstruction; a sluggish one supports it, with an indeterminate gray zone in between (this is exactly the question a hydronephrosis workup is trying to settle when CT can't).
A poorly functioning kidney can't respond to furosemide because it can't make enough urine to flush itself — so the washout looks "obstructed" when it isn't. Dehydration and a full bladder cause the same fake-positive. Always interpret the diuretic curve in light of how well the kidney actually works.
Question 2: Is a tight renal artery causing the hypertension? (the captopril study)
Now a completely different question. In renovascular hypertension, one renal artery is narrowed (think renal artery stenosis). The kidney downstream is being starved of pressure, so it leans hard on angiotensin II to clamp down its efferent arteriole — the outflow drain of the glomerulus. Squeezing that drain props up the filtration pressure and keeps the kidney limping along.
The trick is to kick the crutch out. You give an ACE inhibitor (classically captopril), which blocks angiotensin II. The efferent arteriole relaxes, the propped-up filtration pressure collapses, and that kidney's function visibly drops on the scan.
A positive captopril study is paradoxical: the stenotic kidney looks worse after the drug than before. You compare a baseline scan to a post-ACE-inhibitor scan, and the affected side shows new or worsened delay in uptake and excretion.
The classic positive finding is asymmetry that appears or worsens after captopril — delayed tracer uptake and a flattened, prolonged curve on the stenotic side. A symmetric, unchanged study makes significant renovascular hypertension unlikely.
Hold ACE inhibitors and ARBs before a captopril renogram or the kidney is already unmasked at baseline and you lose the comparison. And because the drug drops blood pressure, patients are hydrated and monitored during the study.
The one thing to carry out
A renal scan trades spatial detail for physiology — it doesn't draw you a pretty kidney, it tells you whether each one is perfused, working, and draining. Pick MAG3 when function or drainage is the question, add furosemide to separate a blocked pipe from a baggy one, and add captopril when you suspect a narrowed artery is driving the blood pressure. (If you want the nuts and bolts of how Tc-99m tracers are made and behave, that lives with the radiopharmaceuticals reference.)